Dual bronchodilation for the treatment of COPD: From bench to bedside
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15390
Abstract: Because there is a solid pharmacological rationale based on positive interactions between long‐acting muscarinic receptor antagonists (LAMAs) and long‐acting β‐agonists (LABAs) for their ability to relax human airway smooth muscle in vitro alongside several randomised… read more here.
Keywords: bronchodilation; copd; laba fdcs; lama laba ... See more keywords